BE1001168A4 - Quantification de molecules d'acide nucleique et trousse de reactifs mise en oeuvre. - Google Patents

Quantification de molecules d'acide nucleique et trousse de reactifs mise en oeuvre. Download PDF

Info

Publication number: BE1001168A4
Authority: BE; Belgium
Prior art keywords: fragment; probes; hindiii; gene; sep
Prior art date: 1986-02-27

Application number

BE8700177A

Other languages

English (en)

French (fr)

Inventor

Ranki Marjut

Soderlund Hans

Original Assignee

Orion Yhtymae Oy

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-02-27

Filing date

1987-02-26

Publication date

1989-08-08

1987-02-26 Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy

1989-08-08 Application granted granted Critical

1989-08-08 Publication of BE1001168A4 publication Critical patent/BE1001168A4/fr

Links

150000007523 nucleic acids Chemical class 0.000 title claims abstract description 83
108020004707 nucleic acids Proteins 0.000 title claims abstract description 82
102000039446 nucleic acids Human genes 0.000 title claims abstract description 82
239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 20
238000012360 testing method Methods 0.000 claims abstract description 77
108090000623 proteins and genes Proteins 0.000 claims abstract description 55
238000000034 method Methods 0.000 claims abstract description 47
238000009396 hybridization Methods 0.000 claims abstract description 38
108020004999 messenger RNA Proteins 0.000 claims abstract description 19
230000003321 amplification Effects 0.000 claims abstract description 13
238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 13
239000000523 sample Substances 0.000 claims description 136
239000012634 fragment Substances 0.000 claims description 64
239000013612 plasmid Substances 0.000 claims description 41
108020004414 DNA Proteins 0.000 claims description 31
108091008146 restriction endonucleases Proteins 0.000 claims description 26
238000001514 detection method Methods 0.000 claims description 22
108010022394 Threonine synthase Proteins 0.000 claims description 20
239000013598 vector Substances 0.000 claims description 20
102000004419 dihydrofolate reductase Human genes 0.000 claims description 18
108700020796 Oncogene Proteins 0.000 claims description 9
108700024542 myc Genes Proteins 0.000 claims description 9
101150074155 DHFR gene Proteins 0.000 claims description 8
108700039691 Genetic Promoter Regions Proteins 0.000 claims description 8
239000003550 marker Substances 0.000 claims description 8
101710135898 Myc proto-oncogene protein Proteins 0.000 claims description 7
101710150448 Transcriptional regulator Myc Proteins 0.000 claims description 7
238000011144 upstream manufacturing Methods 0.000 claims description 7
102000053602 DNA Human genes 0.000 claims description 6
241000713333 Mouse mammary tumor virus Species 0.000 claims description 6
102100038895 Myc proto-oncogene protein Human genes 0.000 claims description 6
102000004190 Enzymes Human genes 0.000 claims description 5
108090000790 Enzymes Proteins 0.000 claims description 5
239000000126 substance Substances 0.000 claims description 5
229920002477 rna polymer Polymers 0.000 claims description 4
239000002253 acid Substances 0.000 claims description 2
238000004445 quantitative analysis Methods 0.000 claims description 2
101100237844 Mus musculus Mmp19 gene Proteins 0.000 claims 1
238000002955 isolation Methods 0.000 claims 1
238000011002 quantification Methods 0.000 abstract description 8
210000004027 cell Anatomy 0.000 description 46
238000012545 processing Methods 0.000 description 11
239000000243 solution Substances 0.000 description 11
108091032973 (ribonucleotides)n+m Proteins 0.000 description 10
230000000875 corresponding effect Effects 0.000 description 10
238000011088 calibration curve Methods 0.000 description 9
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
239000002299 complementary DNA Substances 0.000 description 8
238000003556 assay Methods 0.000 description 6
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
238000011161 development Methods 0.000 description 5
230000018109 developmental process Effects 0.000 description 5
101150026150 mt gene Proteins 0.000 description 5
239000002773 nucleotide Substances 0.000 description 5
125000003729 nucleotide group Chemical group 0.000 description 5
238000002360 preparation method Methods 0.000 description 5
206010028980 Neoplasm Diseases 0.000 description 4
239000000020 Nitrocellulose Substances 0.000 description 4
201000011510 cancer Diseases 0.000 description 4
239000003814 drug Substances 0.000 description 4
239000000203 mixture Substances 0.000 description 4
229920001220 nitrocellulos Polymers 0.000 description 4
230000010076 replication Effects 0.000 description 4
239000011780 sodium chloride Substances 0.000 description 4
238000013519 translation Methods 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
239000011543 agarose gel Substances 0.000 description 3
238000009835 boiling Methods 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
210000000349 chromosome Anatomy 0.000 description 3
238000004925 denaturation Methods 0.000 description 3
230000036425 denaturation Effects 0.000 description 3
229940079593 drug Drugs 0.000 description 3
238000013518 transcription Methods 0.000 description 3
230000035897 transcription Effects 0.000 description 3
238000005406 washing Methods 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
CKTSBUTUHBMZGZ-SHYZEUOFSA-N 2'‐deoxycytidine Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 CKTSBUTUHBMZGZ-SHYZEUOFSA-N 0.000 description 2
229920000936 Agarose Polymers 0.000 description 2
CKTSBUTUHBMZGZ-UHFFFAOYSA-N Deoxycytidine Natural products O=C1N=C(N)C=CN1C1OC(CO)C(O)C1 CKTSBUTUHBMZGZ-UHFFFAOYSA-N 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
208000026350 Inborn Genetic disease Diseases 0.000 description 2
208000024556 Mendelian disease Diseases 0.000 description 2
102000052708 Recessive Genes Human genes 0.000 description 2
108700005079 Recessive Genes Proteins 0.000 description 2
108020004511 Recombinant DNA Proteins 0.000 description 2
239000003513 alkali Substances 0.000 description 2
230000000295 complement effect Effects 0.000 description 2
230000006835 compression Effects 0.000 description 2
238000007906 compression Methods 0.000 description 2
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
239000007788 liquid Substances 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
238000012958 reprocessing Methods 0.000 description 2
238000011160 research Methods 0.000 description 2
239000012488 sample solution Substances 0.000 description 2
238000000926 separation method Methods 0.000 description 2
108010051423 streptavidin-agarose Proteins 0.000 description 2
206010008805 Chromosomal abnormalities Diseases 0.000 description 1
208000031404 Chromosome Aberrations Diseases 0.000 description 1
102000012410 DNA Ligases Human genes 0.000 description 1
108010061982 DNA Ligases Proteins 0.000 description 1
101100239628 Danio rerio myca gene Proteins 0.000 description 1
102000016911 Deoxyribonucleases Human genes 0.000 description 1
108010053770 Deoxyribonucleases Proteins 0.000 description 1
201000010374 Down Syndrome Diseases 0.000 description 1
206010059866 Drug resistance Diseases 0.000 description 1
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
206010029260 Neuroblastoma Diseases 0.000 description 1
238000000636 Northern blotting Methods 0.000 description 1
239000008118 PEG 6000 Substances 0.000 description 1
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
108020004518 RNA Probes Proteins 0.000 description 1
239000003391 RNA probe Substances 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 1
241001255830 Thema Species 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
238000000376 autoradiography Methods 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
239000008366 buffered solution Substances 0.000 description 1
229910052793 cadmium Inorganic materials 0.000 description 1
BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
230000000711 cancerogenic effect Effects 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
108091092356 cellular DNA Proteins 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
238000010367 cloning Methods 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
239000000470 constituent Substances 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
230000029087 digestion Effects 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
238000000605 extraction Methods 0.000 description 1
230000008175 fetal development Effects 0.000 description 1
210000003754 fetus Anatomy 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
229940094991 herring sperm dna Drugs 0.000 description 1
238000000265 homogenisation Methods 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000005259 measurement Methods 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
229960000485 methotrexate Drugs 0.000 description 1
231100000219 mutagenic Toxicity 0.000 description 1
230000003505 mutagenic effect Effects 0.000 description 1
239000002777 nucleoside Substances 0.000 description 1
-1 nucleoside triphosphate Chemical class 0.000 description 1
210000004940 nucleus Anatomy 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
210000002826 placenta Anatomy 0.000 description 1
230000003169 placental effect Effects 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
208000000587 small cell lung carcinoma Diseases 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
239000001226 triphosphate Substances 0.000 description 1
235000011178 triphosphate Nutrition 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Analytical Chemistry (AREA)
Genetics & Genomics (AREA)
Immunology (AREA)
Microbiology (AREA)
General Health & Medical Sciences (AREA)
Physics & Mathematics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Pathology (AREA)
Oncology (AREA)
Hospice & Palliative Care (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)

BE8700177A 1986-02-27 1987-02-26 Quantification de molecules d'acide nucleique et trousse de reactifs mise en oeuvre. BE1001168A4 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FI860836A FI76119C (fi)	1986-02-27	1986-02-27	Kvantitativ bestaemning av nukleinsyramolekyler och reagensfoerpackning som anvaends vid foerfarandet.

Publications (1)

Publication Number	Publication Date
BE1001168A4 true BE1001168A4 (fr)	1989-08-08

Family

ID=8522222

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BE8700177A BE1001168A4 (fr)	1986-02-27	1987-02-26	Quantification de molecules d'acide nucleique et trousse de reactifs mise en oeuvre.

Country Status (26)

Country	Link
JP (1)	JPS62205800A (de)
KR (1)	KR870008033A (de)
AT (1)	AT393511B (de)
AU (1)	AU603562B2 (de)
BE (1)	BE1001168A4 (de)
CA (1)	CA1287558C (de)
CH (1)	CH675593A5 (de)
DD (1)	DD270383A5 (de)
DE (1)	DE3706285A1 (de)
DK (1)	DK174784B1 (de)
ES (1)	ES2061411A6 (de)
FI (1)	FI76119C (de)
FR (1)	FR2594849B1 (de)
GB (1)	GB2187283B (de)
HU (1)	HU201808B (de)
IE (1)	IE66904B1 (de)
IL (1)	IL81695A (de)
IS (1)	IS3197A7 (de)
IT (1)	IT1202581B (de)
LU (1)	LU86792A1 (de)
NL (1)	NL195097C (de)
NO (1)	NO175380C (de)
NZ (1)	NZ219421A (de)
PT (1)	PT84368B (de)
SE (1)	SE468816B (de)
ZA (1)	ZA871401B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5714380A (en)	1986-10-23	1998-02-03	Amoco Corporation	Closed vessel for isolating target molecules and for performing amplification
IL86724A (en)	1987-06-19	1995-01-24	Siska Diagnostics Inc	Methods and kits for amplification and testing of nucleic acid sequences
EP0304845A3 (de) *	1987-08-28	1991-03-06	Profile Diagnostic Sciences Inc.	Verfahren und Zusammensetzung zum Nachweis der Genexpression
DE68921918T2 (de) *	1988-05-09	1995-09-07	Univ Temple	Verfahren zur Voraussage der Wirksamkeit einer antineoplastichen Behandlung bei einzelnen Patienten.
AU629845B2 (en) *	1988-08-30	1992-10-15	Abbott Laboratories	Detection and amplification of target nucleic acid sequences
WO1990014440A1 (en) *	1989-05-18	1990-11-29	The United States Of America, Represented By The Secretary, United States Department Of Commerce	RNA PROBE FOR DETECTING c-fes mRNA
US5232829A (en) *	1989-09-29	1993-08-03	Hoffmann-La Roche Inc.	Detection of chlamydia trachomatis by polymerase chain reaction using biotin labelled lina primers and capture probes
DK138090D0 (da) *	1990-06-06	1990-06-06	Novo Nordisk As	Diagnostisk analysemetode
DK0534640T3 (de) *	1991-09-23	1997-03-17	Pfizer
US6300058B1 (en)	1992-01-29	2001-10-09	Hitachi Chemical Research Center, Inc.	Method for measuring messenger RNA
GB9210916D0 (en) *	1992-05-21	1992-07-08	Isis Innovation	Nucleic acid quantification
US5580971A (en) *	1992-07-28	1996-12-03	Hitachi Chemical Company, Ltd.	Fungal detection system based on rRNA probes
JPH07509361A (ja) *	1992-07-28	1995-10-19	日立化成工業株式会社	遺伝子検出システム
ES2055661B1 (es) *	1993-01-20	1995-03-01	Univ Malaga	Determinacion de la expresion genica por captura especifica de arn y su cuantificacion directa por electroforesis capilar en zona libre.
GB9309966D0 (en) *	1993-05-14	1993-06-30	Nordion Int Inc	Detection of prostrate-specific antigen in breast tumors
GB9415489D0 (en) *	1994-08-01	1994-09-21	Nordion Int Inc	Detection of prostate-specific antigen in amniotic fluid
AT401062B (de) *	1994-09-26	1996-06-25	Immuno Ag	Verfahren zur quantifizierung von nukleinsäuren
JP5565781B2 (ja)	2010-03-31	2014-08-06	有限会社山口ティー・エル・オー	核酸クロマトグラフ法を利用した肺炎原因菌の検出方法

Citations (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0079139A1 (de) *	1981-10-16	1983-05-18	Orion-yhtymä Oy	Methode und Reagenskombination zur Indentifikation von Mikroorganismen und die Anwendung der Sandwichhybridisierung von Nukleinsäuren hierfür
WO1983003259A1 (en) *	1982-03-15	1983-09-29	Univ Columbia	Method for introducing cloned, amplifiable genes into eucaryotic cells and for producing proteinaceous products
US4442203A (en) *	1981-06-30	1984-04-10	Massachusetts Institute Of Technology	Gene amplification assay for detecting tumor promoters
EP0108564A1 (de) *	1982-11-04	1984-05-16	The Regents Of The University Of California	Methoden zur Feststellung von Oncogenese
FR2559783A1 (fr) *	1984-02-17	1985-08-23	Orion Yhtymae Oy	Reactifs d'acide nucleique perfectionnes et procedes pour leur preparation
GB2169403A (en) *	1985-01-02	1986-07-09	Orion Yhtymae Oy	Identification of nucleic acids
EP0206942A1 (de) *	1985-06-21	1986-12-30	Centre National De La Recherche Scientifique (Cnrs)	DNA-Sequenzen von Archaebakterien die homolog zu dem v-myc-Onkogen sind, durch diese Sequenzen kodierte Proteine, Verfahren zu ihrer Herstellung und ihre immunologischen Anwendungen
US4675283A (en) *	1984-07-19	1987-06-23	Massachusetts Institute Of Technology	Detection and isolation of homologous, repeated and amplified nucleic acid sequences

1986
- 1986-02-27 FI FI860836A patent/FI76119C/fi not_active IP Right Cessation
1987
- 1987-02-25 JP JP62042442A patent/JPS62205800A/ja active Granted
- 1987-02-26 CH CH756/87A patent/CH675593A5/de not_active IP Right Cessation
- 1987-02-26 KR KR870001680A patent/KR870008033A/ko not_active Withdrawn
- 1987-02-26 DK DK198700993A patent/DK174784B1/da not_active IP Right Cessation
- 1987-02-26 NZ NZ219421A patent/NZ219421A/xx unknown
- 1987-02-26 IE IE49687A patent/IE66904B1/en not_active IP Right Cessation
- 1987-02-26 NL NL8700483A patent/NL195097C/nl not_active IP Right Cessation
- 1987-02-26 ZA ZA871401A patent/ZA871401B/xx unknown
- 1987-02-26 ES ES08700776A patent/ES2061411A6/es not_active Expired - Fee Related
- 1987-02-26 DE DE19873706285 patent/DE3706285A1/de active Granted
- 1987-02-26 AT AT431/87A patent/AT393511B/de not_active IP Right Cessation
- 1987-02-26 FR FR878702541A patent/FR2594849B1/fr not_active Expired - Lifetime
- 1987-02-26 PT PT84368A patent/PT84368B/pt unknown
- 1987-02-26 NO NO870794A patent/NO175380C/no unknown
- 1987-02-26 AU AU69275/87A patent/AU603562B2/en not_active Expired
- 1987-02-26 LU LU86792A patent/LU86792A1/fr unknown
- 1987-02-26 BE BE8700177A patent/BE1001168A4/fr not_active IP Right Cessation
- 1987-02-26 CA CA000530691A patent/CA1287558C/en not_active Expired - Lifetime
- 1987-02-26 IS IS3197A patent/IS3197A7/is unknown
- 1987-02-26 IT IT19501/87A patent/IT1202581B/it active
- 1987-02-26 GB GB8704517A patent/GB2187283B/en not_active Expired - Lifetime
- 1987-02-26 HU HU87750A patent/HU201808B/hu unknown
- 1987-02-26 SE SE8700821A patent/SE468816B/sv not_active IP Right Cessation
- 1987-02-27 IL IL81695A patent/IL81695A/xx not_active IP Right Cessation
- 1987-02-27 DD DD87300286A patent/DD270383A5/de unknown

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4442203A (en) *	1981-06-30	1984-04-10	Massachusetts Institute Of Technology	Gene amplification assay for detecting tumor promoters
EP0079139A1 (de) *	1981-10-16	1983-05-18	Orion-yhtymä Oy	Methode und Reagenskombination zur Indentifikation von Mikroorganismen und die Anwendung der Sandwichhybridisierung von Nukleinsäuren hierfür
WO1983003259A1 (en) *	1982-03-15	1983-09-29	Univ Columbia	Method for introducing cloned, amplifiable genes into eucaryotic cells and for producing proteinaceous products
EP0108564A1 (de) *	1982-11-04	1984-05-16	The Regents Of The University Of California	Methoden zur Feststellung von Oncogenese
FR2559783A1 (fr) *	1984-02-17	1985-08-23	Orion Yhtymae Oy	Reactifs d'acide nucleique perfectionnes et procedes pour leur preparation
US4675283A (en) *	1984-07-19	1987-06-23	Massachusetts Institute Of Technology	Detection and isolation of homologous, repeated and amplified nucleic acid sequences
GB2169403A (en) *	1985-01-02	1986-07-09	Orion Yhtymae Oy	Identification of nucleic acids
EP0206942A1 (de) *	1985-06-21	1986-12-30	Centre National De La Recherche Scientifique (Cnrs)	DNA-Sequenzen von Archaebakterien die homolog zu dem v-myc-Onkogen sind, durch diese Sequenzen kodierte Proteine, Verfahren zu ihrer Herstellung und ihre immunologischen Anwendungen

Also Published As

Publication number	Publication date
DE3706285A1 (de)	1987-11-12
IE870496L (en)	1987-08-27
AU6927587A (en)	1987-09-03
AU603562B2 (en)	1990-11-22
DE3706285C2 (de)	1993-02-04
LU86792A1 (fr)	1987-07-24
DD270383A5 (de)	1989-07-26
DK99387A (da)	1987-08-28
NZ219421A (en)	1988-11-29
HU201808B (en)	1990-12-28
FI860836A0 (fi)	1986-02-27
IT8719501A0 (it)	1987-02-26
NL8700483A (nl)	1987-09-16
FR2594849A1 (fr)	1987-08-28
NO175380B (no)	1994-06-27
ES2061411A6 (es)	1994-12-01
IL81695A0 (en)	1987-09-16
PT84368A (en)	1987-03-01
FI76119B (fi)	1988-05-31
SE468816B (sv)	1993-03-22
PT84368B (pt)	1989-10-04
IL81695A (en)	1991-04-15
DK174784B1 (da)	2003-11-10
ZA871401B (en)	1987-10-28
AT393511B (de)	1991-11-11
IS3197A7 (is)	1987-08-28
JPS62205800A (ja)	1987-09-10
SE8700821L (sv)	1987-08-28
KR870008033A (ko)	1987-09-23
CH675593A5 (de)	1990-10-15
NO870794D0 (no)	1987-02-26
GB8704517D0 (en)	1987-04-01
JPH0561920B2 (de)	1993-09-07
NL195097C (nl)	2004-03-17
NO175380C (no)	1994-10-05
GB2187283A (en)	1987-09-03
SE8700821D0 (sv)	1987-02-26
IT1202581B (it)	1989-02-09
NO870794L (no)	1987-08-28
HUT43647A (en)	1987-11-30
DK99387D0 (da)	1987-02-26
FR2594849B1 (fr)	1990-04-20
ATA43187A (de)	1991-04-15
GB2187283B (en)	1990-05-30
IE66904B1 (en)	1996-02-07
CA1287558C (en)	1991-08-13
FI76119C (fi)	1988-09-09
FI860836L (fi)	1987-08-28

Legal Events

Date

Code

Title

Description

2007-12-31

RE20

Patent expired

Owner name: *SANGTEC MOLECULAR DIAGNOSTICS AB

Effective date: 20070226

Publication	Publication Date	Title
LU86792A1 (fr)	1987-07-24	Quantification de molecules d'acide nucleique et trousse de reactifs utilisee
Sato et al.	2002	Downregulation of connexin 43 expression by high glucose reduces gap junction activity in microvascular endothelial cells
US5741677A (en)	1998-04-21	Methods for measuring telomere length
US9216172B2 (en)	2015-12-22	Method for determining effectiveness of cancer treatment by assessing the presence of a KIF5B-RET chimeric gene
CA2323231A1 (fr)	1999-09-16	Criblage differentiel qualitatif
EP0566685B1 (de)	1995-09-13	Verfahren für die bestimmung der antikörpersätze und die t-zellrezeptoren des immunologischen systems
FR2810677A1 (fr)	2001-12-28	Procede de diagnostic in vitro du cancer de la prostate et kit de mise en oeuvre
CN107012241A (zh)	2017-08-04	一种U6、miR 92a及miR 21的三重RT‑qPCR检测方法及试剂盒
EP0188485A1 (de)	1986-07-30	Sonde und verfahren zur diagnose des geschlechts eines embryos
WO2022244807A1 (ja)	2022-11-24	Ｌｔｋ融合遺伝子
Matsunaga et al.	1998	Neuronal src and trk a protooncogene expression in neuroblastomas and patient prognosis
JPH08500731A (ja)	1996-01-30	診断法
Shields et al.	1986	A rapid method for the quantitative measurement of gene dosage: mini-F plasmid concentration as a function of cell growth rate
EP1370653B1 (de)	2007-09-05	Herstellung von kalibratoren und ihre verwendung zur quantifizierung von besonderen nukleotidsequenzen
CN113201592A (zh)	2021-08-03	一种鉴定肿瘤类器官的方法
US20190223848A1 (en)	2019-07-25	Non-invasive ocular biological material gathering device
Endo et al.	2002	Primary malignant lymphoma of the brain: mutation pattern of rearranged immunoglobulin heavy chain gene
EP3853380B1 (de)	2026-01-07	Hochdurchsatzverfahren zur erfassung chromosomischer aberrationen und / oder telomerischer aberrationen
FR2718461A1 (fr)	1995-10-13	Procédé de détection d'un site de restriction dans une séquence d'ADN.
TR2024006099A1 (tr)	2025-11-21	Östrojen reseptörü pozi̇ti̇f meme kanseri̇ hücreleri̇nde hücresel senesensi̇n bi̇yobeli̇rteci̇ olarak kardi̇yotrofi̇n-1'i̇n kullanilmasi
TR2023002223A2 (tr)	2024-09-23	İNSAN KROMOZOM Yq12 BÖLGESİNE VE TÜM KROMOZOMLARIN TELOMER BÖLGELERİNE SPESİFİK İN-SİTU HİBRİDİZASYON TEMELLİ DNA PROB DİZAYNI VE UYGULAMASI
Estrada-Zuniga et al.	0	A Novel RET-GRB2 Fusion in Pheochromocytoma Defies the Classic Paradigm of RET Oncogenic Fusions
FR2844597A1 (fr)	2004-03-19	Methode de diagnostic du rhabdomyosarcome embryonnaire et compositions pharmaceutiques pour le traitement et/ou la prevention du rhabdomyosarcome embryonnaire
FR2844598A1 (fr)	2004-03-19	Methode de diagnostic d'un rhabdomyosarcome et compositions pharmaceutiques pour le traitement et/ou la prevention d'un rhabdomyosarcome
FR2816322A1 (fr)	2002-05-10	Methode de separation d'acide nucleique differemment exprime entre une cellule cible et une cellule de reference